- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 7, 2025
Finance
Strategics back Trimtech’s protein cluster degraders with $31M: Finance Report
Pharma venture arms join founding investors CIC, DDF to back U.K. start-up; plus venture rounds for Garuda, Ataraxis and Callio, and Tenaya’s follow-on
BioCentury | Nov 20, 2024
Discovery & Translation
Science Spotlight: A new obesity target may avoid nausea, muscle loss
BioCentury’s roundup of translational innovation: Embark/Novo discover new obesity target, Canbridge delivers large DMD gene, and more
BioCentury | Sep 19, 2024
Discovery & Translation
Science Spotlight: Cancer prognosis via deep learning, new protein degraders, and more
BioCentury’s roundup of translational innovations
BioCentury | Nov 10, 2023
Discovery & Translation
Shinobi’s immune-protected cell therapies; plus Emugen, AZ and more
BioCentury’s roundup of translational innovations
BioCentury | Feb 1, 2020
Distillery Therapeutics
Agonizing the checkpoint protein VISTA for systemic and cutaneous lupus
Items per page:
1 - 8 of 8